Mangoceuticals, Inc.
MGRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -49.9% | 53.8% | 3.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60.4% | 53.5% | 56.8% | 76.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -8,924% | -2,711.3% | -4,060.3% | -1,593.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,042.8% | -3,221.6% | -4,427.4% | -1,850.9% |
| EPS Diluted | -0.69 | -0.54 | -1.054 | -0.6 |
| % Growth | -27.8% | 48.7% | -75.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |